Skip to content
LinkedIn
Search
Search
The Business of Biofabrication
News
Perspectives
Learn
R.D. Solorzano
February 5, 2026
ARPA-H’s $176M Bet on Bioprinted Organs: Inside the PRINT Program’s Push to End Transplant Shortages
R.D. Solorzano
January 3, 2026
The Business of Biofabrication: What 2025 Taught Us
R.D. Solorzano
December 17, 2025
restor3d Completes First Clinical Cases of Fully Personalized 3D-Printed Knee Replacement System
R.D. Solorzano
December 15, 2025
Revalia Bio Secures ~$30M Government Contract to Build the Future of Human-First Drug Development
R.D. Solorzano
December 11, 2025
Inside Curi Bio’s Human Tissue Platforms: How They Work, What the $10M Series B Will Accelerate, and Why It Matters
R.D. Solorzano
December 10, 2025
Xeltis Secures Nearly €50M to Advance aXess Toward Market Entry as New Data Strengthen Clinical Profile
R.D. Solorzano
December 3, 2025
From Lab to Eye – A World First: How Precise Bio’s 3D-Printed Corneal Implant Really Works
R.D. Solorzano
November 28, 2025
The Rise of the Tiger – Tiger BioSciences: Building a Fully Integrated Platform for Regenerative Medicine
R.D. Solorzano
November 20, 2025
InSphero Acquires Doppl SA, Expanding Its 3D Cell Culture Portfolio with the Gri3D® Platform
R.D. Solorzano
November 17, 2025
Tiger Aesthetics Invests in GenesisTissue to Advance Regenerative Breast Reconstruction
R.D. Solorzano
Previous Page
1
2
3
4
…
13
Next Page
Archives
Subscribe
Subscribed
The Business of Biofabrication
Sign me up
Already have a WordPress.com account?
Log in now.
The Business of Biofabrication
Subscribe
Subscribed
Sign up
Log in
Report this content
View site in Reader
Manage subscriptions
Collapse this bar
The Business of Biofabrication 